Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

Author:

Roberts Matthew J.123ORCID,Papa Nathan4ORCID,Veerman Hans567ORCID,de Bie Katelijne67,Morton Andrew3ORCID,Franklin Anthony13ORCID,Raveenthiran Sheliyan3ORCID,Yaxley William J.3ORCID,Donswijk Maarten L.8ORCID,van der Poel Henk G.567ORCID,Samaratunga Hemamali39ORCID,Wong David10,Brown Nicholas310ORCID,Parkinson Robert10,Gianduzzo Troy311,Kua Boon311,Coughlin Geoffrey D.311,Oprea‐Lager Daniela E.12ORCID,Emmett Louise1314ORCID,van Leeuwen Pim J.57ORCID,Yaxley John W.1311ORCID,Vis André N.56ORCID

Affiliation:

1. Department of Urology Royal Brisbane and Women's Hospital Brisbane Queensland Australia

2. UQ Centre for Clinical Research The University of Queensland Brisbane Queensland Australia

3. Faculty of Medicine The University of Queensland Brisbane Queensland Australia

4. School of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia

5. Department of Urology The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

6. Department of Urology Amsterdam University Medical Centers, VU University Amsterdam The Netherlands

7. Prostate Cancer Network Netherlands Amsterdam The Netherlands

8. Department of Nuclear Medicine The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

9. Department of Pathology Aquesta Uropathology Brisbane Queensland Australia

10. I‐MED Radiology The Wesley Hospital Brisbane Queensland Australia

11. The Wesley Hospital Brisbane Queensland Australia

12. Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam Amsterdam University Medical Centers, VU University Amsterdam The Netherlands

13. Faculty of Medicine University of New South Wales Sydney New South Wales Australia

14. Department of Theranostics and Nuclear Medicine St Vincent's Hospital Sydney New South Wales Australia

Abstract

ObjectivesTo construct and externally calibrate a predictive model for early biochemical recurrence (BCR) after radical prostatectomy (RP) incorporating clinical and modern imaging characteristics of the primary tumour.Patients and MethodsPatients who underwent RP following multiparametric magnetic resonance imaging, prostate biopsy and prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA‐PET/CT), from two centres in Australia and the Netherlands. The primary outcome was biochemical recurrence‐free survival (BRFS), where BCR was defined as a rising PSA level of ≥0.2 ng/mL or initiation of postoperative treatment per clinician discretion. Proportional hazards models to predict time to event were developed in the Australian sample using relevant pre‐ and post‐surgical parameters and primary tumour maximum standardised uptake value (SUVmax) on diagnostic PSMA‐PET/CT. Calibration was assessed in an external dataset from the Netherlands with the same inclusion criteria.ResultsData from 846 patients were used to develop the models. Tumour SUVmax was associated with worse predicted 3‐year BRFS for both pre‐ and post‐surgical models. SUVmax change from 4 to 16 lessened the predicted 3‐year BRFS from 66% to 42% for a patient aged 65 years with typical pre‐surgical parameters (PSA level 8 ng/mL, Prostate Imaging‐Reporting and Data System score 4/5 and biopsy Gleason score ≥4 + 5). Considering post‐surgical variables, a patient with the same age and PSA level but pathological stage pT3a, RP Gleason score ≥4 + 5 and negative margins, SUVmax change from 4 to 16 lessened the predicted 3‐year BRFS from 76% to 61%. Calibration on an external sample (n = 464) showed reasonable performance; however, a tendency to overestimate survival in patients with good prognostic factors was observed.ConclusionTumour SUVmax on diagnostic PSMA‐PET/CT has utility additional to commonly recognised variables for prediction of BRFS after RP.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3